Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$6.27 - $7.7 $62,699 - $77,000
10,000 New
10,000 $63,000
Q3 2023

Nov 08, 2023

BUY
$8.91 - $10.91 $2,735 - $3,349
307 New
307 $2,000
Q1 2021

Apr 12, 2021

SELL
$15.15 - $19.78 $17,422 - $22,747
-1,150 Closed
0 $0
Q4 2020

Jan 11, 2021

SELL
$16.86 - $19.67 $370 - $432
-22 Reduced 1.88%
1,150 $21,000
Q3 2020

Oct 30, 2020

SELL
$15.4 - $20.16 $1,355 - $1,774
-88 Reduced 6.98%
1,172 $20,000
Q2 2020

Jul 30, 2020

BUY
$18.24 - $21.45 $109 - $128
6 Added 0.48%
1,260 $23,000
Q1 2020

Apr 27, 2020

SELL
$16.28 - $25.63 $3,614 - $5,689
-222 Reduced 15.04%
1,254 $25,000
Q4 2019

Jan 17, 2020

SELL
$19.57 - $23.52 $6,614 - $7,949
-338 Reduced 18.63%
1,476 $34,000
Q2 2019

Jul 23, 2019

BUY
$17.59 - $21.1 $70 - $84
4 Added 0.22%
1,814 $38,000
Q1 2019

Apr 09, 2019

SELL
$18.01 - $20.11 $24,997 - $27,912
-1,388 Reduced 43.4%
1,810 $36,000
Q4 2018

Jan 28, 2019

SELL
$17.44 - $21.53 $5,319 - $6,566
-305 Reduced 8.71%
3,198 $59,000
Q3 2018

Oct 18, 2018

SELL
$19.97 - $21.96 $22,046 - $24,243
-1,104 Reduced 23.96%
3,503 $75,000
Q2 2018

Jul 19, 2018

SELL
$20.16 - $24.68 $26,893 - $32,923
-1,334 Reduced 22.45%
4,607 $99,000
Q1 2018

Apr 30, 2018

SELL
$20.31 - $24.95 $446 - $548
-22 Reduced 0.37%
5,941 $126,000
Q4 2017

Feb 02, 2018

BUY
$20.99 - $23.89 $2,057 - $2,341
98 Added 1.67%
5,963 $137,000
Q3 2017

Oct 24, 2017

BUY
$20.07 - $21.89 $117,710 - $128,384
5,865
5,865 $128,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.